What is the current price and market cap of BRN.AX stock?

BRN.AX stock closed at **A$0.18** on 19 Jan 2026 with a market capitalisation of **A$400,937,920.00**. Shares outstanding are **2,358,458,352** and trading volume was **9,167,071** shares that session.

When is BrainChip's next earnings release and why does it matter for BRN.AX stock?

BrainChip's next earnings announcement is scheduled for **4 Mar 2026**. That report will show revenue traction, margins and cash flow, which are key triggers for BRN.AX stock moves because valuation depends on converting pilots into recurring sales.

What price targets does Meyka AI give for BRN.AX stock?

Meyka AI's forecast model projects **A$0.11** (monthly), **A$0.21** (quarterly) and **A$0.19** (yearly). The yearly projection implies **5.77%** upside versus today's price of **A$0.18**. Projections are model-based and not guarantees.

What are the main risks for BRN.AX stock investors?

Main risks for BRN.AX stock include negative operating margins, slow commercial adoption of Akida, high valuation relative to current sales, and episodic volatility from small-cap trading. Monitor cash flow and announced customer wins closely.

AU Stocks

Price A$0.18 BRN.AX BrainChip (ASX) 19 Jan 2026: AI edge growth needs revenue traction

ByHuzaifa Zahoor January 19, 2026January 19, 2026

BRN.AX stock closed at A$0.18 on 19 Jan 2026 after a flat ASX session. Trading volume was 9,167,071 shares with a day range of A$0.17–A$0.18, leaving the share price near its 50-day average of A$0.18. Investors in BrainChip Holdings Ltd (BRN.AX) are watching whether commercial traction for the Akida neuromorphic chips will convert into steady revenue. This report unpacks price action, valuation, technicals and near-term catalysts for BRN.AX stock.